Vol 4 | Issue 1 | Jan-Jun 2019 | page: 35-39 | Rajendra Sakhrekar, K.H.Sancheti, Rajeev Joshi, Parag Sancheti, Ashok K Shyam
Authors: Rajendra Sakhrekar , K.H.Sancheti , Rajeev Joshi , Parag Sancheti , Ashok K Shyam [1,2]
 Department of Orthopedics, Sancheti Institute of Orthopedics and Rehabilitation
 Indian Orthopaedic Research Group, Thane, India
Address of Correspondence
Dr. Ashok Shyam,
Sancheti Institue of Orthopedics and Rehabilitation, Shivajinagar, Pune – 16
Objective: Both non operative and operative procedures are advised for avascular necrosis of femoral head depending on stage of avascular necrosis of femoral head. There are studies which investigate the functional outcomes of non operative and operative management independently. We aim to do a study in which satisfaction and functional outcomes of both conservative-oral bisphosphonates therapy and operative-total hip replacement studied respectively in a single study.
Materials and Method: A prospective cohort study was conducted between period of June 2015 to December 2016. All avascular necrosis of femoral head patients were screened and 100 patients fulfilling the inclusion-exclusion criteria were selected and divided in 2 groups 50 patients in each. Patients were followed for a period of 12 ± 2 months (14 to 19 months). At final follow up patients were evaluated using Harris hip scoring and SF 36 scoring system.
Results: At the mean time of 12 months follow-up, The Harris hip score increased from 45.96 (range, 32 – 65 ) pre-operatively to 89.36 (range, 84 – 96 ) post-operatively and The SF 36 score PCS increased from 30.46 (range, 32 – 52 ) pre-operatively to 39.75 (range, 20 – 50 ) post-operatively and MCS from 37.58 (range, 32 – 52 ) pre-operatively to 50.72 (range, 20 – 50 ) post-operatively for total hip replacement group. While for conservative group the Harris hip score increased from 67.96 (SD +/-5.41) pre-treatment to 73.98 (SD +/-8.86 ) 1 year follow up. While The SF 36 score PCS increased from 35.00 (SD +/-3.64 ) ) pretreatment to 49.75 (SD +/- 3.71) post-treatment and MCS from 40.56 (SD +/-5.41 ) pre- treatment to 51.11 (SD +/-5.41 ) 1 year post- treatment.
Conclusion: We conclude that bisphosphonates are helpful in postponing surgical intervention and retarding the progression of collapse in of avascular necrosis of the femoral head, more markedly in stage-I and stage-II disease. Hence The natural history of avascular necrosis of the femoral head can be favorably altered by bisphosphonates. For stage III and IV AVN, total hip replacement with ceramic on ceramic bearings has good surgical as well as functional outcomes, as evidenced by significant improvement in Harris hip scores, VAS score and SF-36 score, with significant
improvement in post-operative range of motion and mobility.
Type of study: Prospective case series
Keywords: “ AVN femoral head, bisphosphonates, total hip replacement, Harris hip score, SF 36 score.”
1. Agarwala S, Shah SB. Ten-year follow-up of avascular necrosis of femoral head treated with alendronate for 3 years. J Arthroplasty. 2011;26:1128–34
2. Pritchett JW. Statin therapy decreases the risk of osteonecrosis in patients receiving steroids.Clin Orthop Relat Res. 2001;386:173–8
3. Disch AC, Matziolis G, Perka C. The management of necrosis-associated and idiopathic bone-marrow edema of the proximal femur by intravenous iloprost. J Bone Joint Surg Br.2005; 87:560–4.
4. Glueck CJ, Freiberg RA, Sieve L, Wang P. Enoxaparin prevents progression of stages I and II osteonecrosis of the hip. Clin Orthop Relat Res. 2005;435:164
5. Chotanaphuti T, Thongprasert S, Laoruengthana A. Low molecular weight heparin prevents the progression of precollapse osteonecrosis of the hip. J Med Assoc Thai. 2013;96:1326–30.
6. Camporesi EM, Vezzani G, Bosco G, Mangar D, Bernasek TL. Hyperbaric oxygen therapy in femoral head necrosis. J Arthroplasty. 2010;25:118
7. Wang CJ, Wang FS, Huang CC, Yang KD, Weng LH, Huang HY. Treatment for osteonecrosis of the femoral head: Comparison of extracorporeal shock waves with core decompression and bone-grafting. J Bone Joint Surg Am. 2005;87:2380
8. Massari L, Fini M, Cadossi R, Setti S, Traina GC. Biophysical stimulation with pulsed electromagnetic fields in osteonecrosis of the femoral head. J Bone Joint Surg Am.2006;88(Suppl 3):56–60.
9. Marker DR, Seyler TM, Ulrich SD, Srivastava S, Mont MA. Do modern techniques improve core decompression outcomes for hip osteonecrosis? Clin Orthop Relat Res. 2008;466:1093–103.
10. Kim SY, Kim DH, Park IH. Multiple drilling compared with core decompression for the treatment of osteonecrosis of the femoral head. J Bone Joint Surg Br. 2004;86:149.
11. Mont MA, Ragland PS, Etienne G. Core decompression of the femoral head for osteonecrosis using percutaneous multiple small-diameter drilling. Clin Orthop Relat Res.2004;429:131–8
12. Mont MA, Etienne G, Ragland PS. Outcome of nonvascularized bone grafting for osteonecrosis of the femoral head. Clin Orthop Relat Res. 2003;417:84–92.
13. Meyers MH. The treatment of osteonecrosis of the hip with fresh osteochondral allografts and with the muscle pedicle graft technique. Clin Orthop Relat Res. 1978;130:202–9.
14. Iwata H, Torii S, Hasegawa Y, Itoh H, Mizuno M, Genda E, et al. Indications and results of vascularized pedicle iliac bone graft in avascular necrosis of the femoral head. Clin Orthop Relat Res. 1993;295:281–8.
15. Hernigou P, Poignard A, Manicom O, Mathieu G, Rouard H. The use of percutaneous autologous bone marrow transplantation in nonunion and avascular necrosis of bone. J Bone Joint Surg Br. 2005;87:896–902.
16. Gangji V, De Maertelaer V, Hauzeur JP. Autologous bone marrow cell implantation in the treatment of non-traumatic osteonecrosis of the femoral head: Five year followup of a prospective controlled study. Bone. 2011;49:1005
17. Jacobs MA, Hungerford DS, Krackow KA. Intertrochanteric osteotomy for avascular necrosis of the femoral head. J Bone Joint Surg Br. 1989;71:200
18. Maistrelli G, Fusco U, Avai A, Bombelli R. Osteonecrosis of the hip treated by intertrochanteric osteotomy. A four- to 15-year followup. J Bone Joint Surg Br. 1988;70:761–6
19. Zhao G, Yamamoto T, Ikemura S, Motomura G, Mawatari T, Nakashima Y, et al. Radiological outcome analysis of transtrochanteric curved varus osteotomy for osteonecrosis of the femoral head at a mean followup of 12.4 years. J Bone Joint Surg Br. 2010;92:781–6
20. George E. Petsatodis, MD; Pericles Total Hip Arthroplasty with an Alumina Ceramic-on-Ceramic Bearing Results After a Minimum of Twenty Years of follow-up,J Bone Joint Surg 2010 Mar; 92 (3): 639 644http://dx.doi.org/10.2106
21. Issa K, Johnson AJ, Naziri Q, Khanuja HS, Delanois RE, Mont MA. Hip osteonecrosis: Does prior hip surgery alter outcomes compared to an initial primary total hip arthroplasty? J Arthroplasty. 2014;29:162–6.
22. Choy W-S, Kim KJ, Lee SK, Bae KW, Hwang YS, Park CK. Ceramic-on-Ceramic Total Hip Arthroplasty: Minimum of Six-Year Follow-up Study. Clinics in Orthopedic Surgery. 2013;5(3):174-179. doi:10.4055/cios.2013.5.3.174.
23. Nishii T, Sugano N, Miki H, Hashimoto J, Yoshikawa H. Does alendronate prevent collapse in osteonecrosis of the femoral head? Clin Orthop Relat Res. 2006;443:273–9.
24. Lai KA, Shen WJ, Yang CY, Shao CJ, Hsu JT, Lin RM. The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study. J Bone Joint Surg Am. 2005;87:2155–9.
25. Chen CH, Chang JK, Lai KA, Hou SM, Chang CH, Wang GJ. Alendronate in the prevention of collapse of the femoral head in nontraumatic osteonecrosis: A two-year multicenter, prospective, randomized, double-blind, placebo-controlled study. Arthritis Rheum.2012;64:1572–8.
26. Agarwala S, Shah SB. Ten-year follow-up of avascular necrosis of femoral head treated with alendronate for 3 years. J Arthroplasty. 2011;26:1128–34
27. Agarwala S, Jain D, Joshi VR, Sule A. Efficacy of alendronate, a bisphosphonate, in the treatment of AVN of the hip. A prospective open-label study. Rheumatology (Oxford)2005;44:352–9.
28. Jae-WookByun, MD, Taek-Rim Yoon, MD, PhD, Kyung-Soon Park, MD, Jong-KeunSeon, MD , Third-Generation Ceramic-On-Ceramic Total Hip Arthroplasty in Patients Younger Than 30 Years with Osteonecrosis of Femoral Head , J Arthroplasty. 2012 Aug;27(7):1337-43. doi: 10.1016/j.arth.2011.07.004. Epub 2011 Dec 9
29. Roshan P Shah, John A Scolaro, Roger Componovo,Jonathan P Garino,Gwo-ChinCeramic-on-ceramic total hip arthroplasty inpatients younger than 55 years , Journal of Orthopaedic Surgery 2014;22(3):338-41
30. Johannson HR, Zywiel MG, Marker DR, Jones LC, McGrath MS, Mont MA. Osteonecrosis is not a predictor of poor outcomes in primary total hip arthroplasty: A systematic literature review. Int Orthop. 2011;35:465–73.
|How to Cite this Article: Sakhrekar R, Sancheti K H, Joshi R, Sancheti P, Shyam A K.
Avascular Necrosis of Head of Femur – Stage of Arrival in Hospital and Management Options. Journal of Orthopaedic and Rehabilitation 2019 Jan-June; 4(1): 35-39